HopeStageGet research updates
HopeStage
hi@hopestage.com

Built by people with lived experience, between Sydney and Paris.

Back to all studies
CompletedNCT00101569

Liquid aripiprazole acceptability in stable schizophrenia

About this titleRead the official source — NCT00101569
Medication studyAges 18+United States
The study in practice

Understand this study

Who was this study for?

Listed age limits: from 18 years.

Listed locations
Anaheim and 6 more locationsSee all locations and recruitment
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateMarch 2004
Recruitment status
Completed
Enrollment listed in the registry
59
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc.
Sponsor type
Pharmaceutical company
Study type
Drug
Intervention type
Medication / drug
Study phase
Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Locations
United States
Age range
Over 18 Years
Official registry ID
NCT00101569
Official title
Show the full official title

Aripiprazole Oral Acceptability Trial

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Anaheim · National City · North Miami Beach

4 more locations
  • Overland Park
  • Staten Island
  • Oklahoma City
  • Falls Church

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is Otsuka Pharmaceutical Development & Commercialization, Inc., a pharmaceutical company.

Did this study involve medication?

Yes. The study involved medication, including Aripiprazole.

Who was this study for?

Listed age limits: from 18 years.

Want to explore more studies?

Explore studies